Register for our free email digests:
Teva Pharmaceuticals USA Inc.
Division of Teva Pharmaceutical Industries Ltd.
www.tevausa.com
Latest From Teva Pharmaceuticals USA Inc.
Amarin's Vascepa May Face Generic Competition In US Next Year After Patents Ruled Invalid
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Amarin's Vascepa May Face Generic Competition In US Next Year After Patents Ruled Invalid
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Teva Sues FDA For Excluding Copaxone From BLA Transition
Teva and US FDA disagree over whether Copaxone is a protein. While generics are already on the market, Teva wants to assert process patents against future would-be competitors, which the firm cannot do through the ANDA pathway.
Teva Sues FDA For Excluding Copaxone From BLA Transition; Wants To Use Biosimilar Litigation Process
Teva and US FDA disagree over whether Copaxone is a protein. While generics are already on the market, Teva wants to assert process patents against future would-be competitors, which the firm cannot do through the ANDA pathway.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Cancer
- Gynecological, Urological
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Teva Pharmaceuticals USA
- Biocraft Laboratories Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
- Contact Info
-
Teva Pharmaceuticals USA Inc.
Phone: (888) 838-2872
1090 Horsham Rd.
N. Wales, PA 19454
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice